Why Use This Site for Advertisement?
|Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy.||
|Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology.
The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation.
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
|1||Full banner||Located in rotation with other banners on all pages, including the home page|
|2||Home page banner or text links||Located only on the home page. Always visible in 1st or 2nd news item in center of the home page|
|3||Cube banner||Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page|
|4||Text links||Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page|
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Gene Therapy News
- Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy | NEJM - nejm.org
Wed, 27 Sep 2023 23:03:1 GMT
- Study points to new risk in gene therapy death of Terry Horgan - STAT
Wed, 27 Sep 2023 23:03:0 GMT
- [Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Yahoo Finance
Wed, 27 Sep 2023 22:00:0 GMT
- Study finds way to deliver clinically used gene therapy vectors - Devdiscourse
Wed, 27 Sep 2023 20:22:2 GMT
- Accelerated Approval and the Promise of Gene Therapy - Applied Clinical Trials Online
Wed, 27 Sep 2023 20:17:4 GMT
- Study finds way to deliver clinically used gene therapy vectors - ThePrint
Wed, 27 Sep 2023 20:13:4 GMT
- Regeneron Adds Hearing Loss Gene Therapy Program Via Decibel ... - The Hearing Review
Wed, 27 Sep 2023 19:23:4 GMT
- In Mice, Gene Therapy Helps Restore Movement After Spinal Cord ... - U.S. News & World Report
Wed, 27 Sep 2023 16:37:3 GMT
- Cell and Gene Therapy Manufacturing Services Market worth ... - GlobeNewswire
Wed, 27 Sep 2023 16:12:3 GMT
- 6 Considerations for Scaling Fill/Finish for Cell and Gene Therapy - Medical Device and Diagnostics Industry
Wed, 27 Sep 2023 14:31:0 GMT
- Cellular and Gene Therapy CDMO Market In 2023 : Size Projection with Top Countries Data By 2031| [112 Pag - Benzinga
Wed, 27 Sep 2023 12:11:1 GMT
- Gene Therapy Market Size to Reach USD 35.1 Billion By 2032 ... - GlobeNewswire
Wed, 27 Sep 2023 02:40:0 GMT
- Gene Therapy: Understanding, and stopping, the monsters who hate - Pittsburgh Post-Gazette
Tue, 26 Sep 2023 23:31:3 GMT
- Charles River Launches Lentivation Gene Therapy Manufacturing Platform - Contract Pharma
Tue, 26 Sep 2023 18:07:5 GMT
- Florida hospital treats DMD patient with new, $3.2M gene therapy - Becker's Hospital Review
Tue, 26 Sep 2023 17:27:0 GMT